Healthcare Global Enterprises Limited has informed the Exchange regarding Appointment of Dr Manish Mattoo as Chief Executive Officer of the company w.e.f. Jun 30, 2025.

Management Changes View source PDF Explain this filing

HCG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.6%Reaction day

₹540.00

prior close

₹556.95

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+0.1%+1.5% vs market

Hospital peers, median of 21sector-0.3%+2.0% vs sector

On the reaction day the stock moved 1.5 pts more than Nifty Microcap 250 and 2.0 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.5

10m

-1.8

15m

-1.6

30m

-0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.6+0.1+1.5-0.3+2.0

Next day

+0.6-0.2+0.8-0.3+1.0

+2.4+0.3+2.0-0.4+2.7

+2.0+0.9+1.1+1.1+0.9

+2.3+0.8+1.5+0.8+1.5

+2.5+2.2+0.4+0.8+1.7

+1.7+3.4-1.7+0.8+0.9

15d

-1.7-0.8-0.9-1.5-0.2

-1.1+2.9-4.0+6.6-7.7

+12.6+0.8+11.8+6.8+5.8

+24.2+0.0+24.2+7.8+16.4

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 21Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Healthcare Global Enterprises Limited has announced the appointment of Dr. Manish Mattoo as the new Chief Executive Officer of the company. The appointment will take effect from June 30, 2025. The company has informed the stock exchange about this leadership change. No further details about the appointee's background, prior role, or terms of appointment were provided in the filing.

Likely market impact

A new CEO appointment signals a leadership transition at the company, which investors should monitor for any strategic direction changes once Dr. Mattoo assumes charge. The actual impact on the stock will depend on the new CEO's track record and stated vision.